Audit Findings as a Training Tool: Turning FDA Observations into Learning
Understanding the Value of FDA Audit Findings In the life sciences industry, FDA audit findings—including FDA 483 observations—are often viewed as compliance setbacks. However, they can also serve as powerful training tools for organizations seeking to enhance regulatory readiness and operational excellence. By analyzing audit findings and integrating lessons into GxP training programs, companies can […]